Revance Therapeutics Inc (RVNC): I still maintain that given the market t...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	11
Posts	885
Boards Moderated	0
Alias Born	10/27/2003

rwwine

Re: DewDiligence post# 1814

Saturday, 03/06/2021 2:34:41 PM

Saturday, March 06, 2021 2:34:41 PM

I still maintain that given the market that Daxi is going after, RVNC will be very far down the list apropos an FDA inspection from a priority standpoint. I still believe timing for approval is Labor Day as previously shared. It is what it is.....

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RVNC News

Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 01:24:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2024 01:29:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 11:32:37 AM
Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm • PR Newswire (US) • 09/27/2024 01:17:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:15:36 AM
Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/16/2024 09:01:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:06:45 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 09/05/2024 09:27:28 PM
Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 09/05/2024 08:45:25 PM
Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 08/13/2024 01:29:06 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 08/12/2024 09:18:26 PM
Rowley Law PLLC is Investigating Proposed Acquisition of Revance Therapeutics, Inc. • PR Newswire (US) • 08/12/2024 07:18:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 01:20:58 PM
Crown Laboratories and Revance Announce Entry Into Merger Agreement • PR Newswire (US) • 08/12/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 01:00:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:34:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:07:57 PM
Revance Reports Second Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 08/08/2024 08:05:00 PM
Revance to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 • Business Wire • 08/01/2024 08:05:00 PM
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/14/2024 08:05:00 PM
Revance to Participate in Upcoming Investor Conferences • Business Wire • 05/28/2024 08:05:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:33:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:10 PM
Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 05/09/2024 08:06:00 PM
Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia • Business Wire • 05/09/2024 08:05:00 PM

More RVNC News

InvestorsHub NewsWire

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM

Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover